Skip to main content
Caplight Logo









Karma Biotechnologies

Karma Biotechnologies

Private
Torrance, CaliforniaHealthcare & Life Scienceshttps://karmabiotech.com

Last Round

Accelerator

Oct 26, 2023

Total Funding Raised

$500,000

Company Overview

Karma Biotechnologies is a biotechnology company that develops tolerogenic therapeutics and immunotherapy solutions to treat autoimmune diseases, allergies, and food sensitivities.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPin vivo cell therapytolerogenic therapeuticsimmune reprogrammingdrug delivery platformimmuno-oncologyautoimmune disease treatmentdrug discoverybiotech licensinggene deliverycell engineeringnext-gen biologicsplatform biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Karma Biotechnologies Comparables

Compare Karma Biotechnologies with similar companies based on industry and business-model similarity.

Karma Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ahead Therapeutics
77%
AbbVie
77%
Parvus Therapeutics Inc.
76%

Karma Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 26, 2023
GrantJan 10, 2022
SeedOct 14, 2015

Karma Biotechnologies Investors

Notable investors and investment history

Karma Biotechnologies investors
InvestorRounds
Khosla VenturesAccelerator
Tech Coast AngelsAccelerator
IndieBioSeed, Accelerator
SOSVSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors increased 50% MoM to 122.2K.

Karma Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Karma Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Karma Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersTorrance, California
Employee Range2
Year Founded2017
Last FundingOct 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?